The first Alnylam Pharmaceuticals trade was made in Q4 2019. Since then Stanley Druckenmiller bought shares three more times and sold shares on three occasions. The investor sold all their shares in Q1 2023 and doesn't own any shares in Alnylam Pharmaceuticals anymore.